Anaplastic large-cell lymphoma
Concept
International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
2008 · Julie M. Vose, Jamés O. Armitage, et al. · Journal of Clinical Oncology
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 · Anas Younes, Ajay K. Gopal, et al. · Journal of Clinical Oncology
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
2010 · Anas Younes, Nancy L. Bartlett, et al. · New England Journal of Medicine